Carregant...
Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of Small Cell Lung Cancer
With the in-depth study of tumor immunity, immunotherapy represented by immune checkpoint inhibitors has made a great breakthrough in solid tumors. Small cell lung cancer (SCLC) accounts for about 15%-20% of all lung cancers, with high malignancy, early metastasis and lack of effective treatment str...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Chinês |
| Publicat: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-04-01
|
| Col·lecció: | Chinese Journal of Lung Cancer |
| Matèries: | |
| Accés en línia: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.07 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|